PMID- 31327579 OWN - NLM STAT- MEDLINE DCOM- 20200213 LR - 20200213 IS - 1532-818X (Electronic) IS - 0196-0709 (Linking) VI - 40 IP - 5 DP - 2019 Sep-Oct TI - Efficacy and safety of sublingual dust mite drops in children with mono- or polysensitized allergic rhinitis. PG - 755-760 LID - S0196-0709(19)30413-2 [pii] LID - 10.1016/j.amjoto.2019.07.010 [doi] AB - OBJECTIVE: To explore the efficacy and safety of sublingual house dust mite (HDM) drops in children with mono- or polysensitized allergic rhinitis. METHODS: We conducted a retrospective cohort study of 65 children with monosensitized AR and 118 children with polysensitized AR who were scheduled for sublingual administration of HDM drops from January 2015 to June 2016. Interleukin (IL)-2, IL-4, and IL-17alpha, transforming growth factor-beta1 (TGF-beta1), specific immunoglobulin E (IgE), and specific IgG4 were detected by ELISA. The efficacies were assessed using symptoms score and medication score. All the outcomes were measured 1 month before the study and 1 month after the end of the 2-year treatment. RESULTS: The total nasal symptoms score (TNSS) decreased significantly from 11.27 (9.81 +/- 12.73) at baseline to 3.48(1.98 +/- 4.98) at the end of sublingual treatment for the monosensitized AP group (t = 30.00, P < 0.01), and from 11.54(10.04 +/- 13.04) to 3.56 (2.00 +/- 5.16) for the polysensitized AR group (t = 40.05, P < 0.01), respectively. IL-2 and TGF-beta1 increased significantly after treatment in contrast with before treatment in both the monosensitized group and the polysensitized group (both P < 0.01). In contrast, IL-4 and IL-17alpha decreased significantly after treatment compared with the baseline in both groups (both P < 0.01). Sublingual HDM drops were generally safe and well tolerant in both groups. CONCLUSIONS: This study confirmed the efficacy and safety of sublingual AIT in both monosensitized and polysensitized AR patients (Chinese children). CI - Copyright (c) 2019. Published by Elsevier Inc. FAU - Zhang, Yao-Zu AU - Zhang YZ AD - Department of Otolaryngology-Head and Neck Surgery, The Affiliated Children Hospital of Xi'an Jiao Tong University, Shanxi, Xi'an 710003, China. FAU - Luo, Juan AU - Luo J AD - Department of Otolaryngology-Head and Neck Surgery, The Affiliated Children Hospital of Xi'an Jiao Tong University, Shanxi, Xi'an 710003, China. FAU - Wang, Zi-Han AU - Wang ZH AD - Department of Otolaryngology-Head and Neck Surgery, The Affiliated Children Hospital of Xi'an Jiao Tong University, Shanxi, Xi'an 710003, China. FAU - Wang, Jie AU - Wang J AD - Department of Otolaryngology-Head and Neck Surgery, The Affiliated Children Hospital of Xi'an Jiao Tong University, Shanxi, Xi'an 710003, China. Electronic address: wangjie0112@icloud.com. LA - eng PT - Journal Article DEP - 20190716 PL - United States TA - Am J Otolaryngol JT - American journal of otolaryngology JID - 8000029 SB - IM MH - Administration, Sublingual MH - Adolescent MH - Animals MH - Case-Control Studies MH - Child MH - Child, Preschool MH - China MH - Databases, Factual MH - Dermatophagoides farinae/*immunology MH - Female MH - Humans MH - Immunization MH - Immunotherapy/adverse effects/*methods MH - Male MH - Patient Safety MH - Prognosis MH - Pyroglyphidae/*immunology MH - Retrospective Studies MH - Rhinitis, Allergic/diagnosis/immunology/*therapy MH - Treatment Outcome OTO - NOTNLM OT - Allergic rhinitis OT - Efficacy OT - House dust mite OT - Immunotherapy EDAT- 2019/07/23 06:00 MHDA- 2020/02/14 06:00 CRDT- 2019/07/23 06:00 PHST- 2019/05/04 00:00 [received] PHST- 2019/07/12 00:00 [revised] PHST- 2019/07/16 00:00 [accepted] PHST- 2019/07/23 06:00 [pubmed] PHST- 2020/02/14 06:00 [medline] PHST- 2019/07/23 06:00 [entrez] AID - S0196-0709(19)30413-2 [pii] AID - 10.1016/j.amjoto.2019.07.010 [doi] PST - ppublish SO - Am J Otolaryngol. 2019 Sep-Oct;40(5):755-760. doi: 10.1016/j.amjoto.2019.07.010. Epub 2019 Jul 16.